Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AQ and SP vs CQ for Malaria in Pregnancy
NCT00131703Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Mar 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of amodiaquine and sulfadoxine + pyrimethamine in Malaria (4 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoints: Prevalence of parasitaemia on day 14 post treatment and Prevalence of parasitaemia on day 28 post treatment. Started Mar 2003; status: completed.
02
Drugs
amodiaquinesulfadoxine + pyrimethamine
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT00131703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00131703.